Saturday 17 October 2026
Export DYAI’s income statement to Excel — free account
Dyadic International Inc.
DYAI Healthcare Biotechnology
Dyadic International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 million, down 11.6% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS was flat, free cash flow fell 1,298.5% and total debt was flat, each against the same quarter a year earlier.
0.41
0.01
−2.38%
Follow DYAI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
2 | 2 | 2 | 2 |
| (244.15%) | (397.80%) | (2,826.83%) | 522.58% | ||
| (65.38%) | (74.11%) | (92.86%) | (103.88%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(98.06%) | (118.61%) | (161.47%) | (301.98%) | |
Average Days of Receivables |
103.83 | 132.92 | 96.71 | 126.57 | |
Free Cash Flow per Share |
(0.13) | (0.17) | (0.16) | (0.20) | |
Free Cash Flow |
(4.63) | (5.70) | (5.72) | (7.40) | |
| Other line items | |||||
Cash ROIC |
(25.89%) | (38.50%) | (51.30%) | (101.10%) | |
Accounts Receivable Turnover |
4.97 | 4.46 | 6.07 | 3.68 | |
Accounts Payable Turnover |
2.59 | 3.48 | 3.73 | 4.10 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
192.77 | 134.05 | 137.50 | 93.54 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
67.08% | 69.72% | 56.09% | 48.37% | |
Selling, General and Administrative Expense of Revenue |
178.17% | 186.44% | 155.49% | 162.38% | |
Share Based Compensation of Revenue |
30.30% | 30.10% | 22.18% | 17.05% | |
Interest Coverage |
(15.36) | (15.78) | (15.74) | (16.62) | |
Operating CF/Net income |
0.63 | 0.77 | 0.78 | 0.97 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.10 | 0.09 | 0.10 | 0.10 | |
Operating CF per Share |
(0.13) | (0.17) | (0.16) | (0.20) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates